Blumenthal poses for a photo outside The Fat Duck on Nov 19 (2025). The three Michelin-starred establishment now offers a lite version of its signature menu, inspired by the lack of appetite Blumenthal experienced while on tirzepatide. — AFP
When Michelin-starred British chef Heston Blumenthal turned to anti-obesity jabs to lose weight, his appetite evaporated and he realised the popularity of such medications risked biting into restaurant sales.
So he devised a menu-lite, offering small plates of his star menu – “The Journey”, priced at GBP350 (RM1,922.15) per person – at his Fat Duck restaurant in the village of Bray, west of London.
His website describes the new “Mindful Experience” menu launched in October (2025), costing GBP275 (RM1,510.26) per person, as “a journey into the culinary creativity and Wonka-like wonderment of Hestonland”.
It says the menu is “a scaled-back version of each dish”, allowing diners to explore “mindfully, slowly savouring every mouthful, taking the time to detect flavours, textures, aroma”.
Following the United States, injections to treat diabetes and weight loss soared in popularity this year in Britain, where they can be bought after consultations at a high-street pharmacy, or prescribed by doctors.
There are no official British figures for the use of this new generation of appetite-suppressing drugs called GLP-1 agonists, which include semaglutide and tirzepatide.
But some studies say more than 3.5 million Britons could be using them.
‘I wasn’t hungry’
“It’s only just started. It’s just beginning,” the 59-year-old Blumenthal said.
He opened The Fat Duck in 1995, which, nine years later, was crowned with three Michelin stars.
His other restaurants in Dubai and London have also won Michelin accolades.
But the celebrity TV chef, known for his playful and innovative creations combining food and science, has openly talked about his struggles since being diagnosed with bipolar disorder two years ago (2023).
ALSO READ: This type of bipolar patient often appears outwardly normal
The medication he was prescribed led him to gain weight – some 40kg.
His doctor proposed weight-loss drugs.
“When I first started to take it, I was not hungry at all.
“It was bizarre really.
“It didn’t put me off eating, but it was just I was full without being full,” Blumenthal said.
He lost 20kg in three months, but happily, the jabs did not kill his tastebuds.
A chance for reinvention
But the chef “realised that there’s a danger for restaurants”.
“This is going to have a huge impact on how we eat, on eating out in general.”
ALSO READ: Big Pharma could affect Big Food with obesity drugs, says Big Finance
He saw it as “a big challenge, but a thrilling one – an opportunity to rethink, re-examine, reinvent”.
His smaller plates menu starts with a “Nitro-poached aperitif”, i.e. a lime and green tea mousse created with liquid nitrogen, which melts in the mouth in seconds.
A signature dish, “Beside the Sea”, transports diners to the seaside through taste, sound and smell.
While customers dine on edible sand and a crab ice-cream, they listen to seagulls and the sound of waves through headphones.
British government figures show that nearly two-thirds of adults are either overweight or obese, and the British National Health Service (NHS) is staggering under patient demand for the jabs.
Faced with long waiting lists, hundreds of thousands have flocked to pharmacies prepared to pay upwards of GBP175 (RM961.08) for a month’s worth of jabs, with the costs rising for higher doses.
Changing tastes
Blumenthal’s smaller menu has been a huge success, with only one of the first 80 customers saying they were not full after eating.
The chef – who these days finds himself spending 10 minutes chewing on a raisin, analysing the taste – said he does not think he could now tuck into a full plate.
“It’s too big,” he explained.
“When there’s less food, you can value it more.
“There’s something about taking a mouthful and really concentrating on it, which changes the way your body is receiving it.”
He is not the only chef to realise tastes are changing.
Indian chef Atul Kochhar told Britain’s Channel 4 TV outlet that he had launched a smaller plates offering.
He “knew there would be an impact on our business” of the anti-obesity jabs, adding that “I’d be lying if I was saying I wasn’t worried”.
“A lot of people were saying, ‘It’s a bit too much of food, we won’t be able to eat it, we don’t want to waste it’.
“So we decided to come with a kind of miniature plate.” – By Caroline Taïx/AFP
